Version history

{
  "session_id": "sess_SDA-2026-04-04-frontier-connectomics-84acb35a_20260412-095156",
  "round_number": 4,
  "agent_persona": "persona-synthesizer",
  "agent_backend": "minimax/MiniMax-M2.7",
  "action": "synthesize",
  "content": "\n\n{\n  \"ranked_hypotheses\": [\n    {\n      \"rank\": 1,\n      \"title\": \"Hippocampal-Cortical Memory Circuit Disconnection as Primary Driver of AD Cognitive Decline\",\n      \"mechanism\": \"Synaptic disconnection between hippocampus, entorhinal cortex, and posteromedial parietal cortex progressively disrupts memory consolidation networks, measurable via DTI tractography before overt atrophy.\",\n      \"target_gene\": \"Not applicable (circuit-level)\",\n      \"confidence_score\": 0.85,\n      \"novelty_score\": 0.55,\n      \"feasibility_score\": 0.80,\n      \"impact_score\": 0.90,\n      \"composite_score\": 0.77,\n      \"testable_prediction\": \"Longitudinal DTI tracking of uncinate fasciculus and parahippocampal cingulum will predict MCI-to-AD conversion with >75% accuracy in asymptomatic carriers of APOE-ε4.\",\n      \"skeptic_concern\": \"Correlation between structural disconnection and cognitive decline may not establish causality; upstream molecular drivers remain unspecified.\"\n    },\n    {\n      \"rank\": 2,\n      \"title\": \"CDK5-Mediated Tau Propagation Along DMN Structural Connectivity Gradients\",\n      \"mechanism\": \"CDK5 hyperactivation in hub neurons drives tau phosphorylation and trans-synaptic spread through connected networks, creating a vulnerability gradient weighted by structural connectivity density.\",\n      \"target_gene\": \"CDK5\",\n      \"confidence_score\": 0.60,\n      \"novelty_score\": 0.75,\n      \"feasibility_score\": 0.50,\n      \"impact_score\": 0.85,\n      \"composite_score\": 0.67,\n      \"testable_prediction\": \"Conditional CDK5 knockout in layer II/III pyramidal neurons of PCC will reduce phospho-tau burden in connected medial PFC regions in 3xTg-AD mice at 12 months.\",\n      \"skeptic_concern\": \"The 'independent of amyloid proximity' claim is unsupported; amyloid-tau synergistic toxicity likely modulates propagation kinetics and regional vulnerability.\"\n    },\n    {\n      \"rank\": 3,\n      \"title\": \"Functional Hyperconnectivity as Compensatory Mechanism vs. Early Pathology Marker\",\n      \"mechanism\": \"Early-stage hyperconnectivity within DMN and between DMN and frontal regions compensates for accumulating tau burden, but transitions to hypoconnectivity as synaptic failure ensues, creating a biphasic trajectory.\",\n      \"target_gene\": \"Not applicable (network-level)\",\n      \"confidence_score\": 0.65,\n      \"novelty_score\": 0.70,\n      \"feasibility_score\": 0.70,\n      \"impact_score\": 0.75,\n      \"composite_score\": 0.69,\n      \"testable_prediction\": \"rs-fMRI longitudinal monitoring in preclinical AD subjects will demonstrate hyperbolic connectivity trajectory: hyperconnectivity at baseline transitions to hypoconnectivity 18-24 months before cognitive symptom onset.\",\n      \"skeptic_concern\": \"Hyperconnectivity findings are highly heterogeneous across studies; may reflect cohort-specific effects rather than universal AD trajectory.\"\n    }\n  ],\n  \"consensus_points\": [\n    \"Structural disconnection measured by DTI reliably tracks cognitive decline progression and is measurable before atrophy\",\n    \"The hippocampus and DMN hub regions represent the most vulnerable nodes in AD-related connectome disruption\",\n    \"Network-level dysfunction precedes and predicts regional atrophy in AD progression\"\n  ],\n  \"dissent_points\": [\n    \"Whether tau propagation operates independently of amyloid-β or requires amyloid as a priming event remains unresolved (Skeptic challenges Theorist's independence claim)\",\n    \"Functional hyperconnectivity represents beneficial compensation vs. pathological hypersynchrony remains debated\"\n  ],\n  \"debate_summary\": \"The debate converges on hippocampal-cortical disconnection as the most translationally actionable hypothesis for AD staging, while mechanistic debates center on whether CDK5-tau propagation requires amyloid co-factors. Expert consensus prioritizes circuit-level measurable biomarkers over molecular propagation models for near-term clinical application, though both frameworks offer complementary windows into AD progression when integrated with longitudinal connectomics.\"\n}",
  "tokens_used": "1012"
}